PGI

DNA profiling solutions for Defense Applications.

Aerospace, Defense & HLS
Private

Company Overview

Snapshot

Founded in March 2025, PGI operates with 1–10 employees and has secured one pre-seed funding round. The company is actively developing advanced DNA profiling solutions for military and law enforcement applications, enhancing real-time field operations.

Business overview

PGI Defense Tech specializes in providing rapid, cost-effective, and highly accurate DNA profiling solutions. The company integrates advanced forensic capabilities with global databases to improve real-time decision-making in critical scenarios for military and law enforcement. Operating within the Aerospace, Defense & HLS sector, PGI's technology serves defense, safety & security, healthcare & life sciences, and government & city markets.

Strategic signal

In November 2024, news highlighted PGI's innovative approach to DNA diagnostics, specifically mentioning its PerMe platform. This indicates the company's focus on leveraging its core DNA profiling technology for broader applications beyond defense, potentially signaling future expansion into personalized health or advanced diagnostic markets. For investors, this suggests a strategic validation of PGI's underlying technology and its potential for diversified revenue streams.

Company Intelligence Q&A

What is PGI's primary focus?
PGI Defense Tech focuses on developing rapid, cost-effective, and highly accurate DNA profiling solutions for military and law enforcement applications, enhancing real-time field operations.
When was PGI founded?
PGI was founded in March 2025.
What markets does PGI serve?
PGI serves defense, safety & security, healthcare & life sciences, and government & city markets with its DNA profiling technology.
What is PGI's product development stage?
PGI's product, including its Chen platform, is currently in the R&D stage, as of August 2026. The company is actively developing advanced DNA profiling solutions for military and law enforcement applications.
What was a key development for PGI in late 2024?
In November 2024, PGI's PerMe platform was highlighted in news reports for its potential to revolutionize DNA diagnostics, indicating progress in its technological applications.